Skip to main content

GSK vs Pfizer: Founders, CEOs and History

GSK was founded in 1715 by Silvanus Bevan, Joseph Nathan, John K. Smith and is led by Luke Miels. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.

Company facts

GSK

Founded
1715
Headquarters
London, United Kingdom
Current CEO
Luke Miels
Employees
66,800

Pfizer

Founded
1849
Headquarters
New York, New York
Current CEO
Albert Bourla
Employees
75,000

Founders

GSK

  • Silvanus Bevan

    Silvanus Bevan was a Quaker apothecary who opened a pharmacy at Plough Court in the City of London in 1715. The business later became Allen & Hanburys, a respiratory-medicine specialist that Glaxo acquired in 1958, which is why GSK dates its history to 1715.

  • Joseph Nathan

    Joseph Nathan emigrated from London to New Zealand and founded a general trading business in Wellington. In 1904 the firm began producing dried milk at Bunnythorpe and sold it as baby food under the Glaxo name.

  • John K. Smith

    John K. Smith opened a drugstore in Philadelphia in 1830. Mahlon Kline joined the business as a bookkeeper in 1865, it became Smith, Kline & Co. in 1875, and Smith, Kline & French after acquiring French, Richards & Co. in 1891.

  • Mahlon Kline

    Mahlon Kline joined John K. Smith's Philadelphia drug business as a bookkeeper in 1865 and became a partner as it grew into a wholesale and manufacturing company, renamed Smith, Kline & Co. in 1875.

  • Henry Wellcome

    Henry Wellcome was a US-born pharmacist who co-founded Burroughs Wellcome & Co. with Silas Burroughs in London in 1880. The company popularised compressed tablets under the 'Tabloid' trademark and later funded major research laboratories.

GSK founders in full

Pfizer

  • Charles Pfizer

    Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.

  • Charles Erhart

    Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…

Pfizer founders in full

CEOs and their tenures

GSK

  1. Jean-Pierre Garnier2000–2008

    Former Chief Executive Officer

    Garnier executed one of the largest corporate mergers in pharmaceutical history, effectively creating the modern GSK conglomerate.

    Source
  2. Andrew Witty2008–2017

    Former Chief Executive Officer

    Witty provided steady leadership during a period of significant macroeconomic volatility following the 2008 financial crisis.

    Source
  3. Emma Walmsley2017–2025

    Former Chief Executive Officer

    Walmsley modernized a sprawling, inefficient corporate giant, transforming GSK into a focused, agile biopharmaceutical enterprise.

    Source
  4. Luke Miels2026–present

    Chief Executive Officer

    Joined GSK in 2017 as President of Global Pharmaceuticals and later served as Chief Commercial Officer before succeeding Emma Walmsley on January 1, 2026.

    Source
GSK CEO history in full

Pfizer

  1. Ian Read2010–2018

    Chief Executive Officer

    He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.

    Source
  2. Albert Bourla2019–present

    Chairman and Chief Executive Officer

    A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.

    Source
  3. Dave Denton2022–2026

    Chief Financial Officer

    As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.

    Source
  4. Chris Boshoff2025–present

    Chief Scientific Officer and President, Research & Development

    He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.

    Source
  5. Cecile Guegan2026–present

    Interim Chief Financial Officer

    She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.

    Source
Pfizer CEO history in full

Timeline: GSK and Pfizer side by side

  1. 1715GSK

    Silvanus Bevan opens Plough Court pharmacy

    Silvanus Bevan opens a pharmacy at Plough Court in London, the business that later became Allen & Hanburys and GSK's oldest root.

  2. 1830GSK

    John K. Smith opens a Philadelphia drugstore

    John K. Smith's Philadelphia drugstore is the start of the business that became Smith, Kline & French.

  3. 1849Pfizer

    Pfizer Founded

    Charles Pfizer and Charles Erhart founded the company in Brooklyn.

  4. 1880GSK

    Burroughs Wellcome & Co. founded

    Henry Wellcome and Silas Burroughs found Burroughs Wellcome & Co. in London.

  5. 1904GSK

    Glaxo dried milk launched in New Zealand

    Joseph Nathan & Co. begins producing dried milk at Bunnythorpe, New Zealand, sold under the Glaxo name.

  6. 1944Pfizer

    Penicillin Scale-Up

    Pfizer helped industrialize penicillin production during World War II.

  7. 1958GSK

    Glaxo acquires Allen & Hanburys

    Glaxo buys Allen & Hanburys, bringing the Plough Court lineage and a respiratory business into the group.

  8. 1995GSK

    Glaxo merges with Wellcome

    Glaxo acquires Wellcome plc to form Glaxo Wellcome.

  9. 1998Pfizer

    Viagra Approved

    The FDA approved Viagra in 1998.

  10. 2000GSK

    GlaxoSmithKline formed

    Glaxo Wellcome and SmithKline Beecham merge in December 2000 to create GlaxoSmithKline, headquartered in the UK.

  11. 2000Pfizer

    Warner-Lambert Deal

    Pfizer acquired Warner-Lambert, adding Lipitor.

  12. 2009Pfizer

    Wyeth Acquired

    Pfizer bought Wyeth in 2009 for about $68 billion.

  13. 2015GSK

    Consumer healthcare joint venture with Novartis

    GSK and Novartis combine their consumer health businesses in a joint venture majority-owned by GSK, as part of an asset swap in which GSK sold its oncology portfolio to Novartis.

  14. 2017GSK

    Shingrix approved; Emma Walmsley becomes CEO

    Emma Walmsley becomes CEO in April 2017, and the FDA approves the Shingrix shingles vaccine in October 2017.

  15. 2019Pfizer

    Albert Bourla becomes CEO

    Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.

  16. 2020Pfizer

    BioNTech COVID Vaccine Partnership

    Pfizer and BioNTech brought Comirnaty through emergency authorization.

  17. 2022GSK

    Haleon demerged

    GSK demerges its consumer health business as Haleon plc in July 2022 and shortens its name to GSK plc.

  18. 2023GSK

    Arexvy approved

    The FDA approves Arexvy in May 2023 as the first RSV vaccine for adults aged 60 and older.

  19. 2023Pfizer

    Seagen Acquisition

    Pfizer completed the $43 billion Seagen acquisition.

  20. 2025GSK

    Exdensur and Blenrep approved in the US

    GSK wins US approvals including Blujepa (March), Blenrep (October) and the twice-yearly asthma biologic Exdensur (December 2025).

  21. 2025Pfizer

    Chris Boshoff Becomes CSO

    Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.

  22. 2025Pfizer

    Metsera Acquisition

    Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.

  23. 2025Pfizer

    FY2025 Revenue Base

    Pfizer reported $62.579 billion of FY2025 revenue.

  24. 2026GSK

    Luke Miels becomes CEO

    Luke Miels succeeds Emma Walmsley as Chief Executive Officer on January 1, 2026.

  25. 2026GSK

    Nuvalent acquisition completed

    GSK completes its $10.6 billion acquisition of Nuvalent in July 2026, adding the lung-cancer drugs Jideytro and neladalkib.

  26. 2026Pfizer

    Innovent Oncology Collaboration

    Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.

Acquisitions

GSK

  • Nuvalent2026$10.6B
  • efimosfermin alfa (from Boston Pharmaceuticals)2025$1.2B
  • IDRx2025$1B
  • Sierra Oncology2022$1.9B
All GSK acquisitions

Pfizer

  • Metsera, Inc.2025$7B
  • Seagen Inc.2023$43B
  • Medivation Inc.2016$14B
  • Wyeth2009$68B
  • Pharmacia Corporation2003$60B
  • Warner-Lambert Company2000$111B
All Pfizer acquisitions

Questions about GSK vs Pfizer

Who is the CEO of GSK plc and Pfizer Inc.?

GSK plc is led by Luke Miels and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was GSK plc founded vs Pfizer Inc.?

GSK plc was founded in 1715 — 134 years before Pfizer Inc., which was founded in 1849. GSK plc's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Pfizer Inc..

How many employees does GSK plc have compared to Pfizer Inc.?

GSK plc employs approximately 66,800 people, while Pfizer Inc. employs approximately 75,000. Pfizer Inc. has the larger workforce at 75,000 employees, compared to GSK plc's 66,800. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are GSK plc and Pfizer Inc. headquartered?

GSK plc is headquartered in United Kingdom and Pfizer Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded GSK plc and Pfizer Inc.?

GSK plc was founded by Silvanus Bevan, Joseph Nathan, John K. Smith, Mahlon Kline, Henry Wellcome. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.

Which company has a longer operating history — GSK plc or Pfizer Inc.?

GSK plc has been operating for approximately 311 years, making it the more established of the two companies. Pfizer Inc. has been in operation for around 177 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the GSK vs Pfizer overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.